Post hoc data link CagriSema to 25% weight loss in women
The figure comes from an after-the-fact subgroup analysis rather than a prespecified trial endpoint, Pharmacy Times reports.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 22 13:46 ETSource: Pharmacy Times
The wire
- 01Post hoc analysis reported by Pharmacy Times ties the amylin-GLP-1 combination CagriSema to roughly 25% weight loss among women.
- 02Sex-based response differences matter to prescribers and operators setting expectations for the next generation of incretin combinations.
- 03Post hoc subgroup findings are exploratory and do not carry the weight of the primary trial result; full details were not reported here.
From the source
Read at pharmacytimes.comCagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
